(Total Views: 609)
Posted On: 01/12/2020 2:44:28 PM
Post# of 153815
Recently, the preclinical company sold for $ 2.5 billion, I do not rule out BO, a major partnership for NASH, cancers ...
CYDY has hired one marketing and transaction support agency, now one person who obviously has experience with similar things, SEC rules, probably uplisting, etc.
NP talks about $ 10 a share, otherwise he can hardly keep things to himself ...
NP said a total of 32 indications, of which 22 cancers, statistically, at least one other partnership must occur.
CYDY has hired one marketing and transaction support agency, now one person who obviously has experience with similar things, SEC rules, probably uplisting, etc.
NP talks about $ 10 a share, otherwise he can hardly keep things to himself ...
NP said a total of 32 indications, of which 22 cancers, statistically, at least one other partnership must occur.
(2)
(1)
